Stay informed about the latest developments in ApoE4-related Alzheimer's research and our advocacy efforts
Watch the recording of our successful webinar featuring Dr. Juan Fortea discussing groundbreaking advancements in APOE4 research and Alzheimer's prevention strategies.
Watch Webinar RecordingPeer-reviewed publication of BROADWAY Phase 3 trial substudy suggests CETP inhibition could play a role in preventing or delaying early-stage Alzheimer's disease.
Read MoreStanford researchers challenge traditional views on APOE4, exploring new therapeutic approaches that could transform how we understand and treat Alzheimer's disease.
Read MoreGroundbreaking research published in Nature Cell Death & Disease reveals novel mechanisms of neuronal cell death in Alzheimer's, opening new pathways for therapeutic intervention.
Read MoreNew research reveals APOE4 homozygotes represent a distinct genetic form of Alzheimer's disease, with near-full penetrance by age 85.
Read MoreApoE4 Alzheimer's Alliance Launches to Advocate for ApoE4 Patients, Urges FDA Action
Read MoreApoE4 Alzheimer's Alliance's letter to the FDA Commissioner outlining six key priorities
Read MoreThe unusual genetic inheritance that could change Alzheimer's treatment.
Read MoreConfirmed research shows women accumulate tau tangles faster than men, potentially explaining higher Alzheimer's rates in women.
Read MoreGroundbreaking research published in Nature reveals new insights into Alzheimer's disease mechanisms and potential treatments.
Read MoreNIH study defines a major genetic form of Alzheimer's disease, providing new insights into disease mechanisms.
Read MoreNew research published in Frontiers in Aging Neuroscience reveals important findings about Alzheimer's disease progression.
Read MoreStanford researchers discover how a gene mutation contributes to Alzheimer's disease development.
Read More